within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L04A_Immunosuppressants.L04AE05_Etrasimod;

model Etrasimod
  extends Pharmacolibrary.Drugs.ATC.L.L04AE05;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>L04AE05</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Etrasimod is a selective sphingosine 1-phosphate receptor modulator used for the treatment of moderate to severe ulcerative colitis. It is an orally administered immunomodulatory drug approved for medical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following single and multiple doses of oral etrasimod 2 mg.</p><h4>References</h4><ol><li><p>Lee, CA, et al., &amp; Grundy, JS (2024). Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults. <i>Clinical pharmacology in drug development</i> 13(5) 534–548. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1379&quot;>10.1002/cpdd.1379</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38345530/&quot;>https://pubmed.ncbi.nlm.nih.gov/38345530</a></p></li><li><p>Darpo, B, et al., &amp; Grundy, JS (2024). Cardiovascular Evaluation of Etrasimod, a Selective Sphingosine 1-phosphate Receptor Modulator, in Healthy Adults: Results of a Randomized, Thorough QT/QTc Study. <i>Clinical pharmacology in drug development</i> 13(4) 326–340. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.1388&quot;>10.1002/cpdd.1388</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38441346/&quot;>https://pubmed.ncbi.nlm.nih.gov/38441346</a></p></li><li><p>Bencardino, S, et al., &amp; Danese, S (2023). Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis. <i>Journal of clinical medicine</i> 12(15) –. DOI:<a href=&quot;https://doi.org/10.3390/jcm12155014&quot;>10.3390/jcm12155014</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37568417/&quot;>https://pubmed.ncbi.nlm.nih.gov/37568417</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Etrasimod;
